Cortisol
From DrugPedia: A Wikipedia for Drug discovery
(New page: Hydrocortisone(Cortisol) Pubchem(5754) The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of...) |
|||
| Line 33: | Line 33: | ||
|- | |- | ||
|} | |} | ||
| - | + | {| border="1;width:100%; height:200px;style=text-align:center" | |
| + | |+'''Table I:''' | ||
| + | |- | ||
| + | ! style="background:brown; color:white" |Physical Property | ||
| + | ! style="background:brown; color:white" |Value | ||
| + | ! style="background:brown; color:white" |Units | ||
| + | ! style="background:brown; color:white" |Temp (deg C) | ||
| + | ! style="background:brown; color:white" |Source | ||
| + | |- | ||
|Melting Point | |Melting Point | ||
|220 | |220 | ||
| Line 43: | Line 51: | ||
|320 | |320 | ||
|mg/L | |mg/L | ||
| - | |25 | + | |25 |
|EXP | |EXP | ||
|- | |- | ||
| Line 55: | Line 63: | ||
|5.77E-08 | |5.77E-08 | ||
|atm-m3/mole | |atm-m3/mole | ||
| - | |25 | + | |25 |
|EST | |EST | ||
|- | |- | ||
| Line 61: | Line 69: | ||
|1.14E-10 | |1.14E-10 | ||
|cm3/molecule-sec | |cm3/molecule-sec | ||
| - | |25 | + | |25 |
|EST | |EST | ||
|- | |- | ||
| - | + | |} | |
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source | Organism Test Type Route Reported Dose (Normalized Dose) Effect Source | ||
|man | |man | ||
Revision as of 09:03, 24 October 2008
Hydrocortisone(Cortisol)
Pubchem(5754)
The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.
Lipinski’s “Rule of Five” Prediction for a Compound’s ABSORPTION OR PERMEABILITY PROPERTIES 4 GOOD 3 INDETERMINATE 2 INDETERMINATE 1 INDETERMINATE 0 POOR
Pathway(C00735,D00088) C21-Steroid hormone metabolism Neuroactive ligand-receptor interaction Prostate cancer
Target glucocorticoid receptor Activity Glucocorticoid
|59369 |2Q1V |Ortlund EA, Bridgham JT, Redinbo MR, Thornton JWCrystal structure of an ancient protein: evolution by conformational epistasisScience v317, p.1544-1548 |- |59811 |2V95 |Klieber MA, Underhill C, Hammond GL, Muller YACorticosteroid-binding globulin, a structural basis for steroid transport and proteinase-triggered releaseJ. Biol. Chem. v282, p.29594-29603 |- |64401 |2VDY |Zhou A, Wei Z, Stanley PL, Read RJ, Stein PE, Carrell RWThe S-to-R transition of corticosteroid-binding globulin and the mechanism of hormone releaseJ. Mol. Biol. v380, p.244-251 |- |}
| Physical Property | Value | Units | Temp (deg C) | Source |
|---|---|---|---|---|
| Melting Point | 220 | deg C | EXP | |
| Water Solubility | 320 | mg/L | 25 | EXP |
| Vapor Pressure | 1.35E-13 | mm Hg | 25 | EST |
| Henry's Law Constant | 5.77E-08 | atm-m3/mole | 25 | EST |
| Atmospheric OH Rate Constant | 1.14E-10 | cm3/molecule-sec | 25 | EST |
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source |man |TDLo |oral |400mg/kg/10D- (400mg/kg) |BEHAVIORAL: CHANGES IN PSYCHOPHYSIOLOGICAL TESTS |Psychopharmacology Vol. 145, Pg. 260, 1999. |- |mouse |LD50 |subcutaneous |> 500mg/kg (500mg/kg) |Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. Vol. 24(3), Pg. 26, 1990. |rat |LD50 |intraperitoneal |150mg/kg (150mg/kg) |Japanese Journal of Pharmacology. Vol. 21, Pg. 377, 1971. |- |rat |LD50 |subcutaneous |449mg/kg (449mg/kg) |Toxicology and Applied Pharmacology. Vol. 8, Pg. 250, 1966. |- |}
